Merastin Reduces Weight, Hip Size in Human Study
News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial.
News hit earlier this month that Merastin, a proprietary plant extract from InterHealth Nutraceuticals, managed to significantly improve weight loss and reduce waist and hip size in a double-blind, placebo-controlled human trial. The findings were presented at Obesity 2011, the Obesity Society’s annual scientific meeting.
Researchers led by Judith Stern, ScD, professor at the University of California, Davis assigned 100 patients to 800 mg of Merastin or placebo for eight weeks. Subjects were instructed to walk five days a week and follow a standard 2000-calorie diet daily.
Compared to reductions in the placebo group, Merastin supplementation was associated with average reductions of 8.2 lbs in body weight, 2.3 inches in waist size, and 1.3 inches in hip size.
Merastin is a blend of Sphaeranthus indicus flower heads and mangosteen (Garcinia mangostana) fruit rind. Results of the trial were exhibited at last week’s SupplySide West show in Las Vegas.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.
